| Application no. and date | 05784163.7 (espacenet) (Federated) (European Patent Register), 20050916 | | Patent/reg. no. and date | DK/EP 1802302, 20161026 | | Publication date | 20070704 | | Priority no. and date | DE 102004049008, 20041005 | | EP pub. no. and date |
EP 1802302 20070704 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P60625DK01 | | Inventor | SACHER, Fritz, Kaiser-Karl-Strasse 27
55435 GAU-ALGESHEIM, DE,
TSCHAIKIN, Marion, Pfungstaedter Strasse 11
64297 Darmstadt, DE,
KOELSCH, Stephan, Dirolfstrasse 14
67549 Worms, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4174 (2006.01) , A61P 31/16 (2006.01) | | Title | NY ANVENDELSE AF ALFA-SYMPATOMIKETIKA MED 2-IMIDAZOLINSTRUKTUR | | Int. application no. | EP2005010026 | | Int. publication no. | WO2006037452 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
